Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Last Updated: January 19, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for Zidebactam


Email this page to a colleague

« Back to Dashboard

What is the drug development status for Zidebactam?

Zidebactam is an investigational drug.

There have been 5 clinical trials for Zidebactam. The most recent clinical trial was a Phase 1 trial, which was initiated on January 1st 2022.

The most common disease conditions in clinical trials are Urinary Tract Infections, Pyelonephritis, and Infections. The leading clinical trial sponsors are Wockhardt, Quintiles, Inc., and Clinartis.

There are sixteen US patents protecting this investigational drug and one hundred and forty-three international patents.

Recent Clinical Trials for Zidebactam
TitleSponsorPhase
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)Medpace, Inc.Phase 3
Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP)WockhardtPhase 3
Plasma and Intrapulmonary Concentrations Study of WCK 5222WockhardtPhase 1

See all Zidebactam clinical trials

Clinical Trial Summary for Zidebactam

Top disease conditions for Zidebactam
Top clinical trial sponsors for Zidebactam

See all Zidebactam clinical trials

US Patents for Zidebactam

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Zidebactam ⤷  Try it Free Beta-lactamase inhibitors Novartis AG (Basel, CH) ⤷  Try it Free
Zidebactam ⤷  Try it Free Controlled release dosage form TRIASTEK, INC. (Nanjing, CN) ⤷  Try it Free
Zidebactam ⤷  Try it Free Oral drug dosage forms having desired drug release profiles and uses thereof Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
Zidebactam ⤷  Try it Free Pharmaceutical compositions comprising antibacterial agents WOCKHARDT LIMITED (Chikalthana, Aurangabad, IN) ⤷  Try it Free
Zidebactam ⤷  Try it Free Compartmented pharmaceutical dosage forms Triastek, Inc. (Nanjing, CN) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Zidebactam

Drugname Country Document Number Estimated Expiration Related US Patent
Zidebactam Argentina AR109737 2036-09-28 ⤷  Try it Free
Zidebactam Australia AU2017335405 2036-09-28 ⤷  Try it Free
Zidebactam Brazil BR112019002195 2036-09-28 ⤷  Try it Free
Zidebactam Canada CA3030373 2036-09-28 ⤷  Try it Free
Zidebactam Chile CL2019000232 2036-09-28 ⤷  Try it Free
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
Harvard Business School
AstraZeneca
Boehringer Ingelheim
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.